Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,042 | 14 | 95.5% |
| Education | $49.00 | 1 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $297.36 | 3 | $0 (2024) |
| Melinta Therapeutics, LLC | $229.94 | 5 | $0 (2024) |
| ABBVIE INC. | $208.54 | 4 | $0 (2024) |
| Gilead Sciences, Inc. | $130.05 | 1 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $120.60 | 1 | $0 (2024) |
| La Jolla Pharmaceutical Company | $104.37 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,091 | 15 | ViiV Healthcare Company ($297.36) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/27/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $116.54 | General |
| 08/22/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Rezzayo | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: ANTIBIOTICS | ||||||
| 06/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $130.05 | General |
| 06/11/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $96.90 | General |
| Category: HIV | ||||||
| 05/16/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: ANTIFUNGALS | ||||||
| 04/24/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $83.92 | General |
| Category: HIV | ||||||
| 04/15/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/28/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/20/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $120.60 | General |
| Category: ANTIBIOTIC | ||||||
| 03/14/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: ANTIFUNGALS | ||||||
| 02/27/2024 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $104.37 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 02/21/2024 | Melinta Therapeutics, LLC | Vabomere (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTIBIOTICS | ||||||
| 02/19/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/05/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Education | In-kind items and services | $49.00 | General |
| Category: ANTIFUNGALS | ||||||
| 01/11/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: ANTI-INFECTIVE | ||||||
About Dr. Matthew Stack, MD
Dr. Matthew Stack, MD is a Infectious Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2018. The National Provider Identifier (NPI) number assigned to this provider is 1962994491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Stack, MD has received a total of $1,091 in payments from pharmaceutical and medical device companies, with $1,091 received in 2024. These payments were reported across 15 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,042).
Practice Information
- Specialty Infectious Disease
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location Houston, TX
- Active Since 05/31/2018
- Last Updated 05/19/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1962994491
Products in Payments
- Vabomere (Drug) $125.00
- DALVANCE (Drug) $124.99
- NUZYRA (Drug) $120.60
- XERAVA (Drug) $104.37
- APRETUDE (Biological) $96.90
- Rezzayo (Drug) $94.68
- DOVATO (Drug) $83.92
- AVYCAZ (Drug) $83.55
- Kimyrsa (Drug) $10.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Houston
Dr. Richard Hamill, M.d, M.D
Infectious Disease — Payments: $883,001
Roy Chemaly, M.d, M.D
Infectious Disease — Payments: $815,305
Dr. Joseph Gathe, M.d, M.D
Infectious Disease — Payments: $774,683
Ben Barnett, M.d, M.D
Infectious Disease — Payments: $515,688
Dr. Amar Safdar, M.d, M.D
Infectious Disease — Payments: $309,168
Dr. Luis Ostrosky, M.d, M.D
Infectious Disease — Payments: $242,843